|
1）Camenisch TD, McDonald JA. Hyaluronan: is bigger better？ Am J Respir Cell Mol Biol. 2000; 23: 431-3
|
|
|
|
2）Termeer CC, Hennies J, Voith U, et al. Oligosaccharides of hyaluronan are potent activators of dendritic cells. J Immunol. 2000; 165: 1863- 70
|
|
|
|
|
|
3）Termeer C, Sleeman JP, Simon JC. Hyaluronan-magic glue for the regulation of the immune response？ Trends Immunol. 2003; 24: 112-4
|
|
|
|
|
4）McKee CM, Lowenstein CJ, Horton MR, et al. Hyaluronan fragments induce nitric-oxide synthase in murine macrophages through a nuclear factor kappaB-dependent mechanism. J Biol Chem. 1997; 272: 8013-8
|
|
|
|
|
|
5）Dadi HK, Greaves AM, Cox DW, et al. Identification of a polymorphism in human CD44. Nucleic Acids Res. 1991; 19: 969
|
|
|
|
|
|
6）Aruffo A, Stamenkovic I, Melnick M, et al. CD44 is the principal cell surface receptor for hyaluronate. Cell. 1990; 61: 1303-13
|
|
|
|
|
|
7）Jalkanen S, Jalkanen M. Lymphocyte CD44 binds the COOH-terminal heparin-binding domain of fibronectin. J Cell Biol. 1992; 116: 817-25
|
|
|
|
|
|
8）Ehnis T, Dieterich W, Bauer M, et al. A chondroitin/dermatan sulfate form of CD44 is a receptor for collagen XIV (undulin). Exp Cell Res. 1996; 229: 388-97
|
|
|
|
|
|
9）Weber GF, Ashkar S, Glimcher MJ, et al. Receptor-ligand interaction between CD44 and osteopontin (Eta-1). Science. 1996; 271: 509-12
|
|
|
|
|
|
10）Foster LC, Arkonac BM, Sibinga NE, et al. Regulation of CD44 gene expression by the proinflammatory cytokine interleukin-1beta in vascular smooth muscle cells. J Biol Chem. 1998; 273: 20341-6
|
|
|
|
|
|
11）DeGrendele HC, Estess P, Picker LJ, et al. CD44 and its ligand hyaluronate mediate rolling under physiologic flow: a novel lymphocyte-endothelial cell primary adhesion pathway. J Exp Med. 1996; 183: 1119-30
|
|
|
|
|
|
12）Knudson CB. Hyaluronan receptor-directed assembly of chondrocyte pericellular matrix. J Cell Biol. 1993; 120: 825-34
|
|
|
|
|
|
13）Oertli B, Fan X, Wuthrich RP. Characterization of CD44-mediated hyaluronan binding by renal tubular epithelial cells. Nephrol Dial Transplant. 1998; 13: 271-8
|
|
|
|
|
|
14）Hart SP, Dougherty GJ, Haslett C, et al. CD44 regulates phagocytosis of apoptotic neutrophil granulocytes, but not apoptotic lymphocytes, by human macrophages. J Immunol. 1997; 159: 919-25
|
|
|
|
|
|
15）Teder P, Vandivier RW, Jiang D, et al. Resolution of lung inflammation by CD44. Science. 2002; 296: 155-8
|
|
|
|
|
|
16）Termeer C, Benedix F, Sleeman J, et al. Oligosaccharides of Hyaluronan activate dendritic cells via toll-like receptor 4. J Exp Med. 2002; 195: 99-111
|
|
|
|
|
|
17）Trinchieri G, Sher A. Cooperation of Toll-like receptor signals in innate immune defence. Nat Rev Immunol. 2007; 7: 179-90
|
|
|
|
|
|
18）Jiang D, Liang J, Fan J, et al. Regulation of lung injury and repair by Toll-like receptors and hyaluronan. Nat Med. 2005; 11: 1173-9
|
|
|
|
|
|
19）Taylor KR, Yamasaki K, Radek KA, et al. Recognition of hyaluronan released in sterile injury involves a unique receptor complex dependent on Toll-like receptor 4, CD44, and MD-2. J Biol Chem. 2007; 282: 18265-75
|
|
|
|
|
|
20）del Fresno C, Otero K, Gomez-Garcia L, et al. Tumor cells deactivate human monocytes by up-regulating IL-1 receptor associated kinase-M expression via CD44 and TLR4. J Immunol. 2005; 174: 3032-40
|
|
|
|
|
|
21）Liang J, Jiang D, Griffith J, et al. CD44 is a negative regulator of acute pulmonary inflammation and lipopolysaccharide-TLR signaling in mouse macrophages. J Immunol. 2007; 178: 2469-75
|
|
|
|
|
|
22）Scheibner KA, Lutz MA, Boodoo S, et al. Hyaluronan fragments act as an endogenous danger signal by engaging TLR2. J Immunol. 2006; 177: 1272-81
|
|
|
|
|